Načítá se...
Recombinant adeno-associated virus vectors in the treatment of rare diseases
INTRODUCTION: An estimated 25 million Americans are living with rare diseases. Adeno-associated virus (AAV)-mediated gene therapy is an emerging therapeutic option for the more than 7,000 identified rare diseases. This paper highlights the benefits of AAV therapy compared to conventional small molec...
Uloženo v:
| Vydáno v: | Expert Opin Orphan Drugs |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5034874/ https://ncbi.nlm.nih.gov/pubmed/27668135 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/21678707.2015.1039511 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|